ACAD
17.55
-0.68
-3.73%
AEMD
5.4
+0.81
+17.65%
APRI
1.17
-0.02
-1.68%
ARNA
1.47
-0.01
-0.68%
ATEC
0.209
+0.017
+8.741%
CNAT
1.65
0.00
0.00%
CRXM
0.228
-0.001
-0.393%
CYTX
0.133
-0.007
-5.000%
DXCM
56.25
-2.01
-3.45%
GNMK
5.04
+0.08
+1.61%
HALO
7.43
+0.26
+3.63%
ILMN
138.46
-0.24
-0.17%
INNV
0.05
0.00
0.00%
INO
6.19
+0.41
+7.09%
ISCO
2.61
-0.19
-6.79%
ISIS
57.56
0.00
0.00%
LGND
85.79
-2.47
-2.80%
LPTN
0.155
-0.005
-3.0568%
MBVX
0.529
+0.004
+0.7430%
MEIP
1.06
+0.05
+4.95%
MNOV
4.22
0.00
0.00%
MRTX
19.39
-0.15
-0.77%
MSTX
0.235
+0.005
+2.2174%
NBIX
35.37
+1.67
+4.96%
NUVA
41.82
+0.13
+0.31%
ONCS
1.51
+0.03
+2.03%
ONVO
1.93
+0.01
+0.52%
OREX
1.65
0.00
0.00%
OTIC
13.96
+0.76
+5.76%
QDEL
15.28
-0.12
-0.78%
RCPT
231.96
0.00
0.00%
RGLS
5.85
+0.17
+2.99%
RMD
57.12
-0.62
-1.07%
SCIE
0.001
0.00
-12.5000%
SPHS
1.57
-0.07
-4.27%
SRNE
4.89
+0.39
+8.67%
TROV
3.91
+0.12
+3.17%
VICL
0.32
+0.00
+0.0313%
VOLC
18
0.00
0.00%
ZGNX
9.52
+0.41
+4.50%
ACAD
17.55
-0.68
-3.73%
AEMD
5.4
+0.81
+17.65%
APRI
1.17
-0.02
-1.68%
ARNA
1.47
-0.01
-0.68%
ATEC
0.209
+0.017
+8.741%
CNAT
1.65
0.00
0.00%
CRXM
0.228
-0.001
-0.393%
CYTX
0.133
-0.007
-5.000%
DXCM
56.25
-2.01
-3.45%
GNMK
5.04
+0.08
+1.61%
HALO
7.43
+0.26
+3.63%
ILMN
138.46
-0.24
-0.17%
INNV
0.05
0.00
0.00%
INO
6.19
+0.41
+7.09%
ISCO
2.61
-0.19
-6.79%
ISIS
57.56
0.00
0.00%
LGND
85.79
-2.47
-2.80%
LPTN
0.155
-0.005
-3.0568%
MBVX
0.529
+0.004
+0.7430%
MEIP
1.06
+0.05
+4.95%
MNOV
4.22
0.00
0.00%
MRTX
19.39
-0.15
-0.77%
MSTX
0.235
+0.005
+2.2174%
NBIX
35.37
+1.67
+4.96%
NUVA
41.82
+0.13
+0.31%
ONCS
1.51
+0.03
+2.03%
ONVO
1.93
+0.01
+0.52%
OREX
1.65
0.00
0.00%
OTIC
13.96
+0.76
+5.76%
QDEL
15.28
-0.12
-0.78%
RCPT
231.96
0.00
0.00%
RGLS
5.85
+0.17
+2.99%
RMD
57.12
-0.62
-1.07%
SCIE
0.001
0.00
-12.5000%
SPHS
1.57
-0.07
-4.27%
SRNE
4.89
+0.39
+8.67%
TROV
3.91
+0.12
+3.17%
VICL
0.32
+0.00
+0.0313%
VOLC
18
0.00
0.00%
ZGNX
9.52
+0.41
+4.50%
Home » Archive by Category

Xconomy

Venture Funding Looms Large for San Diego Biopharma Startups

January 29, 2015 – 3:27 pm

Venture capital funding in the San Diego area has recovered from a three-year plunge that accompanied the U.S. financial crisis, according to a recent analysis of a decade’s worth of VC deals. But…

[[Click headline to continue reading.]]

Venture Funding Looms Large for San Diego Biopharma Startups

January 29, 2015 – 3:27 pm

Venture capital funding in the San Diego area has recovered from a three-year plunge that accompanied the U.S. financial crisis, according to a recent analysis of a decade’s worth of VC deals. But…

[[Click headline to continue reading.]]

Venture Funding Looms Large for San Diego Biopharma Startups

January 29, 2015 – 3:27 pm

Venture capital funding in the San Diego area has recovered from a three-year plunge that accompanied the U.S. financial crisis, according to a recent analysis of a decade’s worth of VC deals. But…

[[Click headline to continue reading.]]

Xconomy Is Seeking Great Sales People in Boston and San Francisco

January 28, 2015 – 12:18 pm

When it comes to writing in-depth, daily stories about the business of high technology—in tech, life sciences, and beyond—we at Xconomy believe there are few news organizations that can…

[[Click headline to continue reading.]]

Xconomy Is Seeking Great Sales People in Boston and San Francisco

January 28, 2015 – 12:18 pm

When it comes to writing in-depth, daily stories about the business of high technology—in tech, life sciences, and beyond—we at Xconomy believe there are few news organizations that can…

[[Click headline to continue reading.]]

Xconomy Is Seeking Great Sales People in Boston and San Francisco

January 28, 2015 – 12:18 pm

When it comes to writing in-depth, daily stories about the business of high technology—in tech, life sciences, and beyond—we at Xconomy believe there are few news organizations that can…

[[Click headline to continue reading.]]

Exosome Dx, Aiming to Commercialize “Liquid Biopsies,” Seeks $25M

January 28, 2015 – 5:00 am

It’s the moment of truth for any emerging diagnostics firm: the transition from startup to commercial-stage company. Time to convince insurers that you have something worth paying for, and doctors in…

[[Click headline to continue reading.]]

Exosome Dx, Aiming to Commercialize “Liquid Biopsies,” Seeks $25M

January 28, 2015 – 5:00 am

It’s the moment of truth for any emerging diagnostics firm: the transition from startup to commercial-stage company. Time to convince insurers that you have something worth paying for, and doctors in…

[[Click headline to continue reading.]]

Exosome Dx, Aiming to Commercialize “Liquid Biopsies,” Seeks $25M

January 28, 2015 – 5:00 am

It’s the moment of truth for any emerging diagnostics firm: the transition from startup to commercial-stage company. Time to convince insurers that you have something worth paying for, and doctors in…

[[Click headline to continue reading.]]

Aspyrian Therapeutics Raises $8.5M for New Tumor Immunotherapy

January 26, 2015 – 11:25 pm

San Diego-based Aspyrian Therapeutics, founded in 2010 to advance technology that uses near-infrared light to activate an immune response targeting certain types of tumors, has raised almost $8.5…

[[Click headline to continue reading.]]